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Background: The underlying mechanisms for earlier
hepatitis B e antigen (HBeAg) seroconversion in patients
with chronic hepatitis B virus (CHBV) genotype B (CHBB)
when compared CHBV genotype C (CHBC) are unknown.
Regulatory T cells (Treg) can suppress the function of T cells
and may thus be key players in this immune response. To
investigate changes in the ability of plasmacytoid dendritic
cells (pDCs) in inducing CD4+ CD25+ Treg could explain the
difference of antiviral response in the patients with CHBB
and CHBC.
Methods: 65 patients with CHB were included in this study,
with 20 healthy subjects being used as a control group. The
amount, phenotype, and FOXP3 RNA of CD4+CD25+ Treg in
CD4+ T cells primed by pDCs from CHB patients and healthy
controls were studied by ﬂow cytometry and RT-PCR. The
IL-10 and TGF-b1 of pDC-primed CD4+ T cells were assayed
with the ELISA kits.
Results: The frequency and Treg-inducing capacity of pDCs
were dramatically inceased in both groups of patients with
CHBC and CHBB. CD4+T cells primed by pDC from the
patients with CHBC were more effective than CD4+ T cells
primed by pDC from the patients with CHBB in suppressing
HBV-speciﬁc T-cell responses. A higher percentage of
CD4+CD25+ Treg was detected within the population of
CD4+ T cells primed by pDC from patients with CHBC
compared with patients with CHBB. CD25+Treg from pDC-
primed CD4+ T cells displayed a high Fox P3 messenger RNA
level. The IL-10 and TGF-b1 could be also detectable in the
supernatants of pDC-primed CD4+ T cells.
Conclusion: The lower reduction in Treg-inducing capacity
of pDCs of patients with CHBB than in those with CHBC may
correlate with the outcome of antiviral treatment in CHB
patients and the progression of liver inﬂammation.
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Background: The liver is one of the target organs for dsDNA-
vector mediated gene delivery due to the highly efﬁcient
uptake of gene therapy vectors by hepatocytes. Recently,
double-stranded DNA (dsDNA) was described as pathogen
associated molecular pattern that could be recognized by
an intracellular DNA sensor. The aim of this paper is to
explore the possibility that cytosolic dsDNA may trigger
the innate immune responses of hepatocyte-derived cell
line HepG2.2.15 and therefore regulate the replication of
hepatitis B virus (HBV).
Methods: Poly(dA-dT), a synthetic double-stranded DNA,
was transfected into HepG2.2.15. IFN-b, ISG56, TNF-a were
detected by real time RT-PCR. HBsAg and HBeAg were
assayed by ELISA. HBV virion were tested by real-time PCR.
HBV replicative intermedias were detected by southern
blot. pTBK1, IRF3, and NF-úB were tested by western blot.
We also treated the HepG2.2.15 with siTBK1, or siMAVS, or
siDAI, followed by poly(dA-dT) transfection. The expression
of ISG56 were detected by real-time RT-PCR.
Results: IFN-b, ISG56, and TNF-awere induced in
HepG2.2.15 after poly(dA-dT) transfection. The activation
of cytokine involved the activation of NF-úB pathway.
MAVS, but not TBK1 or DAI decreased ISG56 expression.
Surprisingly, HBV replication was up-regulated after
poly(dA-dT) transfection despite the activation of some
ISGs. Furthernmore, results indicated that U0126, an
inhibitor of MAPK-ERK1/2, could block the poly (dA-dT)
enhanced HBV replication. Western blot results showed that
phosphorylated ERK1/2 was attenuated in HepG2.2.15 cells
after poly(dA-dT) stimulation.
Conclusion: IFN/ISG can be induced in hepatocyte-
derived cells after dsDNA transfection. But HBV
replication enhanced, accompanied by decreasing ERK1/2
phosphorylation in response to cytosolic ds-DNA. The results
imply that more careful consideration should be given when
dsDNA vectors are used in HBV-infected disease treatment.
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Background and Objectives: In a recent paper (J. Virology,
83, 2009, 9652 9662), Asabe et al. reported HBV infections
in 9 acutely infected chimpanzees. The doses of the
inoculations with HBVDNA were 1 to 1010 GE/ml for the
9 animals. Results showed that after the HBVDNA reaching
peaks, the HBVDNA of four chimpanzees inoculated with 10
GE/ml and 104 GE/ml became either prolonged or persistent
infections. But the other ﬁve chimpanzees’ HBVDNA
decreased rapidly, and were lower than undetectable levels
at or before the week 39.
Methods: We use a differential equation virus infection
model in aim to explain why the ﬁve chimpanzees’ HBV can
rapidly decrease. The model is described by four variables:
x, y, v, e, representing uninfected cells, infected cells,
free virus (HBVDNA), cytotoxic T lymphocytes cells. The
equation includes 11 parameters: lambda, a, b, d, k, u, m,
n, k1(t), k2, k3. Here m, n, k1(t), k2 change with the time.
Results: We have shown that if a chimpanzee with a virus
reproductive number R0 < 1, it will eventually clear HBV in
its body even infected a large amount of HBV. Based on the
experimental data of the ﬁve chimpanzees, we determine
the model parameters. The simulation data are qualitatively
agreement with the practical ones.
Conclusion: The virus reproductive number R0 < 1 is a
sufﬁcient condition for deleting all infected hepatocytes.
Immune response plays an important role in clearing
infected hepatocytes. The numerical simulations showed
that a chimpanzee with R0 > 1 will become persistent
infection even only infected one virus.
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